Friday, September 26, 2025 |
7:00am |
Check-in and Breakfast in Exhibit Hall |
8:00am | Horizon CME App Overview and CE Housekeeping |
8:10am | Welcome, Introductions, & CE Housekeeping |
8:15am | (01) The Daniel D. Von Hoff Keynote Lecture » TBA |
9:15am | Break | Refreshments in Exhibit Hall |
| Block One: Clinical Trials 101 |
9:40am | (02) Clinical Trials Basics » Lisa Kottschade APRN, MSN, CNP, FAPO – Nurse Practitioner, Melanoma/Cutaneous Oncology-Immunotherapy Toxicity Clinic Associate Professor of Oncology Oncology APP Research Lead Mayo Clinic |
10:05am | (03) Clinical Trial Designs » Erin Pierce, MSN, APRN, FNP-C – Nurse Practitioner, Associate Clinical Investigator HonorHealth Research Institute |
10:30am | (04) How to Be a Good Investigator » Bridget O’Brien, DNP, APRN, FNP-BC, AOCNP – Associate Professor, Director of FNP Program Rush University Oncology Nurse Practitioner Northwestern Medicine |
10:50am | (05) Q+A Panel and Discussion: Block One » Faculty from Sessions 02-04 |
11:00am |
Gather for Lunch |
11:10am | Lunch |
11:55am | Dessert – Refreshments in Exhibit Hall |
| Block Two: Targeted Drug Development and Biomarker Testing |
12:10pm | (06) Drug Development Process for Targeted Agents » Erin Pierce, MSN, APRN, FNP-C – Nurse Practitioner, Associate Clinical Investigator HonorHealth Research Institute |
12:35pm | (07) Biomarkers in Solid Tumors » TBA |
1:00pm | (08) Biomarkers in Hematologic Malignancies » Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN – Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic |
1:25pm | (09) Q+A Panel and Discussion: Block Two » Faculty from Sessions 06-08 |
1:40pm | Message from the Cancer Charities |
1:55pm | Break – Trivia for Charity in the Exhibit Hall |
| Block Three: The Evolving Role of Advanced Practice Providers in Clinical Trials |
2:15pm | (10) From Being a Sub-investigator to Clinical Trial Leadership » Gayle Jameson, MSN, ACNP-BC, AOCN – Nurse Practitioner, Associate Clinical Investigator HonorHealth Research Institute |
2:40pm | (11) Involvement in Clinical Trial Protocol Development/Writing/Review and Obtaining Funding » Gayle Jameson, MSN, ACNP-BC, AOCN – Nurse Practitioner, Associate Clinical Investigator HonorHealth Research Institute |
3:05pm | (12) Working with a Biostatistician When Developing Your Own Investigator-Initiated Trial » TBA |
3:30pm | (13) Getting a Trial Through Startup/Operationalizing a Trial » Donna D. Catamero, ANP-BC, OCN, CCRC – Associate Director, Myeloma Research Adjunct Faculty, Mount Sinai Phillips School of Nursing The Mount Sinai Health System |
| Block Four: The Evolving Role of Advanced Practice Providers in Clinical Trials (Continued) |
3:55pm | (14) How to Interpret Research Data and Develop a Conference Presentation/Publication » Carol Peyton Bryant, DNP, RN, ACNP, CCRN – Advanced Practice Provider Supervisor Hematology/Medical Oncology Division Co-Associate Chair for NP PAs Department of Medicine Instructor in Medicine Mayo College of Medicine and Science |
4:20pm | (15) Q+A Panel and Discussion: Block Three/Four » Faculty from Sessions 10-14 |
5:15pm | Networking Reception – Exhibit Hall |
Saturday, September 27, 2025 |
7:00am | Check-in |
7:55am | Horizon CME App Overview and CE Housekeeping |
8:00am | Welcome and Introductions |
| Block Five: Adverse Event Management in the Setting of a Clinical Trial |
8:05am | (16) Recent Updates in Multiple Myeloma » Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN – Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic |
8:30am | Gather for Breakfast |
8:35am | Breakfast Symposium sponsored by TBA » TBA |
9:20am | Transition Break |
9:25am | (17) AEs with Targeted Agents » Rachel Conybeare, ANP-BC, AOCNP – Clinical Trials Nurse Practitioner Department of Nursing, Head and Neck Medical Oncology Memorial Sloan Kettering Cancer Center |
9:50am | (18) AEs with Immune Checkpoint Inhibitors » Diane Barber, PhD, ANP-BC, AOCNP, FAANP, FAAN – Manager of Advanced Practice Providers Department of Investigational Cancer Therapeutics MD Anderson |
10:15am | (19) AE Grading & Documentation » Madeline Merrill, AGNP-BC, MSN – Clinical Trials Nurse Practitioner Memorial Sloan Kettering Cancer Center |
10:40am | (20) Q+A Panel and Discussion: Block Five » Faculty from Sessions 16-18 |
10:50am | Break – Refreshments in the Exhibit Hall |
11:05am | Poster Session |
| Block Six: Clinical Trial Methodology |
11:50am | (21) Strategies for Patient Recruitment » Kelly Bolton, MD, PhD – Assistant Professor Washington University |
12:10pm | (22) Novel Endpoints for Therapeutic Response in Early Phase Trials » Jordi Rodon Ahnert, MD, PhD – Associate Professor, Investigational Cancer Therapeutics Division of Cancer Medicine The University of Texas MD Anderson Cancer Center |
12:30pm | (23) The Evolution of Agnostic Drug Approval: Where Are We Now? » TBA |
12:50pm | (24) Role of Patient Advocacy in Early Phase Trials » TBA |
1:10pm | (25) Q+A Panel and Discussion: Block Six » Faculty from Sessions 20-23 |
1:30pm | Gather for Lunch |
1:35pm |
Buffet Lunch & Non-CME/CE Presentation Sponsored by TBA » TBA |
2:20pm | Dessert Break in Exhibit Hall |
| Block Seven: Advances With Bispecific Therapy and CAR-T Therapy in Cancer Care |
2:35pm | (26) Advances in Bispecific Therapy and CAR-T Therapy in Hematologic Malignancies » Laura J. Zitella, MS, RN, ACNP-BC, AOCN – Associate Clinical Professor, Hematology Nurse Practitioner University of California, San Francisco |
3:00pm | (27) Advances in Bispecific Therapy in Solid Tumors » TBA |
3:25pm | Break – Refreshments in the Exhibit Hall |
3:40pm | (28) AEs with Bispecific Therapy and CAR-T Therapy in Hematologic Malignancies and Solid Tumors » Laura J. Zitella, MS, RN, ACNP-BC, AOCN – Associate Clinical Professor, Hematology Nurse Practitioner University of California, San Francisco |
4:05pm | (29) Community Coordination of Care in Bispecifics » Charise Gleason, MSN, NP-BC, AOCNP – Corporate Director of Advanced Practice Providers Emory Healthcare Nurse Practitioner Bone Marrow and Stem Cell Transplant Center Winship Cancer Institute of Emory University |
4:30pm | (30) Q+A Panel and Discussion: Block Seven » Faculty from Sessions 25-29 |
4:45pm | Closing Comments |